Related Experiment Videos
Gene therapy for Parkinson's disease.
Patricia A Lawlor1, Matthew J During
1Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand. t.lawlor@auckland.ac.nz
Expert Reviews in Molecular Medicine
|March 6, 2004
Summary
Gene therapy offers a promising approach for Parkinson's disease (PD) by targeting specific brain cells. Several gene-transfer strategies are being explored to address the complex nature of PD and improve patient outcomes.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Parkinson's disease (PD) involves the loss of dopaminergic neurons, leading to motor symptoms.
- Current treatments like levodopa (L-dopa) manage symptoms but do not halt disease progression.
Purpose of the Study:
- To explore gene therapy as a potential treatment for Parkinson's disease.
- To discuss various gene-transfer strategies for PD and their clinical applicability.
Main Methods:
- Review of current gene therapy approaches for PD.
- Analysis of strategies involving dopamine production, neuroprotection, and neuronal circuitry modulation.
Main Results:
- Gene therapy is a promising avenue for PD due to localized pathology and defined transfer sites.
- Multiple gene-transfer strategies are under investigation, including enzyme, growth factor, and phenotypic switching approaches.
Conclusions:
- Gene therapy holds significant potential for treating Parkinson's disease.
- Overcoming hurdles is crucial for translating gene therapy into clinical practice for PD.